First Affiliated Hospital of Wenzhou Medical University
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 1956-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dyyy.xjtu.edu.cn/
Clinical Trials
60
Active:0
Completed:5
Trial Phases
5 Phases
Early Phase 1:4
Phase 1:1
Phase 2:9
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (42 trials with phase data)• Click on a phase to view related trials
Not Applicable
23 (54.8%)Phase 2
9 (21.4%)Phase 4
5 (11.9%)Early Phase 1
4 (9.5%)Phase 1
1 (2.4%)Study of Intramural Spread Pattern in Low Rectal Cancer.
Completed
- Conditions
- Rectal Cancer PatientsRectal Cancer Stage
- First Posted Date
- 2025-10-01
- Last Posted Date
- 2025-10-01
- Target Recruit Count
- 106
- Registration Number
- NCT07202169
- Locations
- 🇨🇳
The First Affiliated Hospital of Whenzhou Medical University, Wenzhou, Zhejiang, China
Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy
Not Applicable
Recruiting
- Conditions
- Cognitive ImpairmentFocal Epilepsy
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-09-25
- Last Posted Date
- 2025-09-25
- Target Recruit Count
- 220
- Registration Number
- NCT07193277
- Locations
- 🇨🇳
First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Comparison of Different Surgical Approaches in Female Rectal Cancer.
Not Applicable
Not yet recruiting
- Conditions
- Rectal Cancer Surgery
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Target Recruit Count
- 200
- Registration Number
- NCT07189780
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
Not Applicable
Not yet recruiting
- Conditions
- Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of BladderNon-Muscle-Invasive Bladder Cancer
- Interventions
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Target Recruit Count
- 106
- Registration Number
- NCT07189793
- Locations
- 🇨🇳
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial
Not Applicable
Not yet recruiting
- Conditions
- Advanced Non-Small Cell Lung Cancer (NSCLC)
- Interventions
- Drug: Arm 2：Fixed Delay GroupDrug: Arm 1： Standard Synchronous GroupDrug: Arm 3： Individualized Delay Group
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Target Recruit Count
- 246
- Registration Number
- NCT07190027
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
News
No news found